Trial intelligence / Profile preview

Diclofenac Sodium Patch for Acute Pain from Soft Tissue Injuries

NCT00931866Phase 3Completed

Sponsor
Cerimon Pharmaceuticals, Inc.
Start
Apr 2009
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute pain and soft tissue injury comparing Diclofenac Sodium Patch with Placebo Patch (2 arms). Primary endpoint: Change in average pain during daily activity at Day 7. Started Apr 2009; status: completed.

02

Drugs

diclofenac
03

Conditions

acute painsoft tissue injury

Beyond the preview

Go deeper on NCT00931866.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00931866.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call